-
Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com
来源: Buzz FX / 07 11月 2024 01:32:16 America/Chicago
Esperion Therapeutics (NASDAQ:ESPR) Rating Increased to Buy at StockNews.com Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) was upgraded by research analysts at
Read more...